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Abstract: This study examined the role of endocannabinoid signaling in 
stress-induced reinstatement of cocaine seeking and explored the interaction 
between noradrenergic and endocannabinergic systems in the process. A 
well-validated preclinical model for human relapse, the rodent conditioned 
place preference assay was used. Cocaine-induced place preference was 
established in C57BL/6 mice using injections of 15 mg/kg cocaine. Following 
extinction of preference for the cocaine-paired environment, reinstatement of 
place preference was determined following 6 min of swim stress, or cocaine 
injection (15 mg/kg, i.p.). The role of endocannabinoid signaling was studied 
using the cannabinoid antagonist AM-251 (3 mg/kg, i.p.). Another cohort of 
mice was tested for reinstatement following administration of the cannabinoid 
agonist CP 55,940 (10, 20 or 40 μg/kg, i.p.). The alpha-2 adrenergic 
antagonist BRL-44408 (5 mg/kg, i.p.) with or without CP 55,940 (20 μg/kg) 
was administered to a third group of mice. We found that: 1) AM-251 blocked 
forced swim-induced but not cocaine-induced reinstatement of cocaine-
seeking behavior; 2) the cannabinoid agonist CP 55,940 did not reinstate 
cocaine-seeking behavior when administered alone but did synergize with a 
non-reinstating dose of the alpha-2 adrenergic antagonist BRL-44408 to 
cause reinstatement. These results are consistent with the hypothesis that 
stress exposure triggers the endogenous activation of CB1 receptors and that 
activation of the endocannabinoid system is required for the stress-induced 
relapse of the mice to cocaine seeking. Further, the data suggests that the 
endocannabinoid system interacts with noradrenergic mechanisms to 
influence stress-induced reinstatement of cocaine-seeking behavior. 
Keywords: cannabinoids, cocaine, norepinephrine, relapse, stress, 
conditioned place preference 
Cocaine abuse and dependence are important problems with 
significant psychosocial, medical and financial implications. One of the 
more troubling aspects of addiction is the persistent vulnerability to 
relapse to drug use that continues even after long periods of 
abstinence. Although relapse can be induced by re-exposure to 
cocaine, drug-associated cues or stress (Childress et al., 1992; See et 
al., 1999; Shaham et al., 2000; Stewart, 2000; Kalivas and McFarland, 
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2003), exposure to stress is particularly injurious given its 
inescapability. The investigation of neurobiological mechanisms at the 
intersection of motivated behavior and stress could prove fruitful in the 
search for potential treatments for stress-induced drug relapse. The 
endocannabinoid system (ECS), including the cannabinoid receptors 
(CB1 and CB2), endocannabinoids (N-arachidonylethanolamine and 2-
arachidonoylglycerol) and enzymes and transporters which control 
synaptic concentrations of endocannabinoids, are attractive targets in 
this regard. 
The preclinical investigation of relapse involves the use of 
reinstatement protocols in which various stimuli are tested for their 
ability to re-establish extinguished drug-seeking behavior (Shaham 
2003). Conditioned place preference is commonly used to study 
reinstatement in mice. Using this method, cocaine-induced conditioned 
place preference becomes extinguished with repeated drug-free 
exposure to the cocaine-paired environment. The ability of various 
stimuli to re-establish the cocaine preference is then tested 
(Tzschentke, 2007). Using this protocol, priming injections of cocaine 
and a variety of stressors have been shown to produce reinstatement 
(Itzhak and Martin, 2002; Kreibich and Blendy, 2004; Ribeiro Do Couto 
et al., 2006; Tzchentke, 2007; Orsini, et al., 2008; Redila and 
Chavkin, 2008; Mantsch et al., 2010). 
There is strong evidence that the ECS is activated in multiple 
brain regions involved in addiction by stress exposure (Di et al, 2005; 
Gorzalka et al., 2008; Patel and Hillard, 2008; Rademacher et al, 
2008; Hill et al., 2009). It is hypothesized that the result of this 
activation in most brain regions is to oppose the effects of stress (Cota 
2008; Gorzalka et al., 2008; Hill et al., 2010). For example, CB1 
receptor knock out animals have increased basal and stress-induced 
HPA activity, (Barna et al., 2004; Cota et al., 2007), CB1 antagonists 
increase basal and stress induced glucocorticoid secretion (Manzanares 
et al., 1999; Patel et al., 2004; Wade et al., 2006), and CB1 agonists 
and clearance inhibitors reduce stress-induced glucocorticoid secretion 
(Patel et al., 2004). 
Central noradrenergic systems also play an important role in the 
physiological response to stress (Abercrombie et al., 1988; Tanaka et 
al., 1991; Finlay et al., 1995) and interactions between the 
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noradrenergic system and cocaine are well documented (Sofuoglu and 
Sewell, 2009). Repeated cocaine exposure produces long-lasting 
adaptations within central noradrenergic systems that can lead to 
enhanced noradrenergic responsiveness during stress (Belej, et al 
1996; Macey, et al 2003; Baumann, et al 2004; Beveridge, et al 2005; 
Lanteri, et al 2008) and norepinephrine (NE) release is required for 
stress-induced drug reinstatement using both rat self-administration 
models (Erb et al., 2000; Leri et al., 2002) and mouse conditioned 
place preference protocols (Mantsch et al., 2010). 
The ECS has a well-established role in enhancing the 
motivational effects and promoting drug seeking and relapse behavior 
of alcohol, nicotine, opioids and marijuana (Tanda and Goldberg, 
2003; Lupica et al., 2004; Gardner, 2005; Cohen et al., 2005). Studies 
of the role of the ECS in the rewarding aspects of cocaine have shown 
inconsistent effects (Fattore et al., 1999; Soria et al., 2005; Xi et al., 
2008; Wiskerke et al., 2008; Orio et al., 2009) but the ECS seems to 
play an important role in relapse behavior. DeVries et al., (2001) 
found that a cannabinoid agonist reinstated cocaine seeking in rats 
that had been conditioned and extinguished in a self-administration 
paradigm and that a cannabinoid antagonist prevented cocaine- and 
cue- but not stress- induced reinstatement of cocaine seeking. 
Cannabinoid mechanisms were also implicated in cocaine-primed 
reinstatement in rats (Xi et al., 2006; Filip et al., 2006). In mice, 
however, cue-induced but not cocaine-induced reinstatement was 
blocked by a cannabinoid antagonist (Ward et al., 2009). Surprisingly, 
given the well-established link between the ECS and stress, there has 
been only one investigation of the role of stress-induced cocaine 
reinstatement (De Vries et al., 2001) and there have been no studies 
on the interaction between the endocannabinoid and noradrenergic 
systems in stress-induced cocaine relapse. 
The purpose of this study was to examine the role of the ECS in 
cocaine- and stress-induced relapse of cocaine seeking behavior and 
its interaction with noradrenergic mechanisms in mice using a 
conditioned place preference reinstatement approach. 
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Experimental Procedures 
Animals 
Male C57BL/6 mice, 8-9 weeks old, were purchased from Harlan 
(Indianapolis, IN). The mice were housed singly in a temperature- and 
humidity-controlled, AAALAC- accredited animal facility under a 12 
h/12 h light/dark cycle (lights on at 7:00 AM) and had access to food 
and water at all times, except when in the experimental chambers. 
The animals were acclimatized for one week in the animal care facility 
before use in the studies. All experiments had been reviewed and 
approved by the Institutional Animal Care and Use Committee and 
were carried out in accordance with the Guide for the Care and Use of 
Laboratory Animals. 
Drugs 
Cocaine HCl was acquired from the National Institute on Drug 
Abuse (Bethesda, MD) through the NIDA Drug Supply Program. CP 
55,940 and AM-251 were purchased from Sigma-Aldrich (St. Louis, 
MO) and BRL-44408 maleate was acquired from Tocris Bioscience 
(Minneapolis, MN). Cocaine and BRL-44408 were dissolved in saline 
(0.9% NaCl solution) and CP 55,940 and AM-251 were dissolved in a 
1:1:18 ratio of ethanol, Cremophor EL (Sigma-Aldrich), and saline. 
Cocaine and BRL-44408 solutions were administered i.p. in a volume 
of 0.1 ml/25 g body weight. CP 55,940 and AM-251 were administered 
i.p. in a volume of 0.1 ml/10 g body weight. Pretreatment times for CP 
55,940, BRL-44408 and AM-251 were 30 min. 
Equipment 
Behavioral testing was conducted using six ENV-3013 three-
chambered mouse place preference chambers from Med-Associates, 
Inc (St. Albans, VT). Two 46.5 × 12.7 × 12.7 cm side compartments 
were each connected to a 7.2 cm × 12.7 cm gray-colored center 
compartment. One side compartment had white walls and a stainless 
steel mesh floor and the other side compartment had black walls and a 
stainless steel grid rod floor. The clear tops of the compartments were 
hinged to permit placement and removal of the mice. Room ceiling 
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lights were turned on and, to balance unconditioned side preference, 
the black compartments were illuminated with additional suspended 
lights, providing a total illumination of approximately 300 lux. 
Automated data collection was accomplished using photobeams (6 
beams for the white and black test areas and 2 beams for the center 
gray area) which were evenly spaced across the length of the chamber 
and interfaced with a computer containing Med-PC software. 
Cocaine-Induced Conditioned Place Preference 
Cocaine-induced conditioned place preference was established 
using an unbiased design in which one of the side compartments was 
randomly designated as the cocaine compartment and the other as the 
saline compartment. On the first day of the procedure, mice were 
placed into the center compartment of the chamber and provided free 
access to both side compartments for 30 minutes in the absence of 
saline or cocaine pretreatment to determine pre-conditioning 
preference. During the 8-day conditioning phase of the experiment, 
mice received cocaine (15 mg/kg, ip) and saline injections on 
alternating days after which time they were confined to the randomly 
designated treatment-appropriate compartment for 30 minutes. After 
the final conditioning session, mice were tested for the expression 
cocaine-induced conditioned place preference by once again placing 
them into the center compartment of the chamber and providing them 
with free access to the side compartments for 30 minutes. Conditioned 
place preference was defined as the change in time spent in the 
cocaine-paired compartment after conditioning compared to the initial 
pre-conditioning session. The 15 mg/kg cocaine dose was selected 
based on previous results (Mantsch et al., 2010). 
Extinction 
Following conditioning, daily extinction training was conducted. 
During the extinction sessions, mice were placed into the center 
compartment and allowed free access to the side compartments for 30 
min. Mice underwent daily extinction training until the conditioned 
place preference for the cocaine-paired compartment during the 
session was reduced by at least 50%. 
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Reinstatement Testing 
The reinstatement sessions were identical to the extinction 
sessions except that mice received exposure to stressors and/or drug 
injections prior to the session. Reinstatement was defined as the 
increase in time spent in the cocaine-paired compartment on the test 
day (reinstatement day) compared to the time spent on the cocaine-
paired compartment on the previous day (extinction day). Mice were 
tested more than once for reinstatement, receiving all treatments 
within a given experiment. The stressors and/or drugs were given in 
counter-balanced order to avoid potential sequence effects. 
Reinstatement sessions were separated by additional extinction 
sessions. Mice were required to reach the extinction criterion once 
again before the next reinstatement test was conducted. 
Forced Swim Stress-Induced Reinstatement Testing 
Forced swim stress (FS)-induced reinstatement was examined 
by placing the mice into a 30 cm h × 20 cm d cylindrical polypropylene 
container filled with water (20-25° C) for 6 min, 24 min after 
pretreatment with drug or respective vehicles. Following FS, mice were 
placed back into their home cages for 1-2 min prior to introduction into 
the center compartment of the place conditioning chamber for 
reinstatement testing. 
Cocaine-Induced Reinstatement Testing 
Reinstatement induced by a cocaine priming injection was 
tested in mice by injection of 15 mg/kg dose of cocaine i.p. 
immediately before placement into the center compartment of the 
place conditioning chamber for reinstatement testing. 
Effect of the CB1 Receptor Antagonist, AM-251, on 
Stress- and Cocaine-Induced Reinstatement 
In order to determine if CB1 receptor activation plays a role in 
stress- or cocaine-induced reinstatement, 24 min prior to forced swim 
testing or 30 minutes prior to cocaine injection, the mice were injected 
with AM-251 or vehicle. The mice were also injected with AM-251 or 
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vehicle 30 minutes before testing in order to determine whether the 
AM-251 or vehicle injection could cause reinstatement. All mice 
received six treatments (FS+ vehicle, FS+AM-251, cocaine+vehicle, 
cocaine+AM-251, AM-251 + vehicle, and vehicle+vehicle) in 
counterbalanced order. Mice reached extinction criterion before 
retesting. 
Reinstatement by the CB1 Receptor Agonist CP 55,940 
In order to determine if CB1 receptor activation alone was 
sufficient to induced reinstatement, mice were tested for reinstatement 
in response to the synthetic CB1 receptor agoninst CP 55,940. Thirty 
minutes prior to testing, mice were injected with vehicle or 10, 20 or 
40 μg/kg doses of CP 55,940. All mice received all 4 treatments in 
counterbalanced order. Mice reached extinction criterion before 
retesting. 
Reinstatement by CP 55,940 in Combination with BRL-
44408 
Another group of mice were tested for reinstatement by CP 
55,940 in combination with a subthreshold dose of the selective alpha-
2 adrenergic receptor antagonist and pharmacological stressor, BRL-
44408, in order to determine if cannabinoid receptor activation could 
potentiate a pharmacological stressor-induced reinstatement and 
whether cannabinoid receptor activation interacted with noradrenergic 
mechanisms to induce reinstatement. It has been shown previously 
that a sufficient dose of BRL-44408 can induce reinstatement 
(Mantsch, et al., 2010). We have found that 5 mg/kg BRL-44408 is a 
subthreshold dose. Therefore, 20 μg/kg CP 55,940 and 5 mg/kg BRL-
44408 were injected i.p. 30 minutes prior to reinstatement testing. 
Statistical Data Analyses 
Statistical analysis was carried out using SigmaPlot 11 statistical 
software (Systat Software, San Jose, CA). Data are expressed as mean 
+/- standard error of the mean. The ability of a drug and/or stress 
procedure to elicit reinstatement was determined by the difference 
between the time spent in the cocaine-paired compartment on the day 
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of testing (reinstatement day) and the preceding extinction session 
(extinction day). Comparisons between effects of different drugs 
and/or stress on reinstatement were also determined. Statistical 
significance was determined by two-way repeated measures (RM) 
ANOVA with post-hoc multiple comparisons using the Holm-Sidak 
method. 
Results 
Establishment of cocaine-induced conditioned place 
preference 
Previous studies had determined that 15 mg/kg cocaine dose 
was optimal for producing conditioned place preference (Mantsch et 
al., 2010). We found significant cocaine-induced conditioned place 
preference, defined as an increase in time spent in the cocaine-paired 
compartment, was observed in each of the experiments (p≤0.001 for 
each experiment). The average number of extinction sessions prior to 
the first reinstatement test session was 5.9. Nineteen percent of mice 
were not tested for reinstatement since they did not display cocaine-
induced conditioned place preference or failed to reach the extinction 
criterion. 
The effect of AM-251 on stress- and cocaine-induced 
reinstatement 
Reinstatement was tested in mice which had been conditioned 
to cocaine and whose place preference had been extinguished. Both FS 
(6 minutes) and cocaine (15 mg/kg, i.p.) produced reinstatement, as 
indicated by significant increases in time spent on the cocaine-paired 
side compared to the preceding extinction day (p<0.05 Holm-Sidak 
following a significant interaction between time (extinction and 
reinstatement day) and treatment (F(5,25)=8.142, p<0.001, two-way 
RM ANOVA, Figure 1). To determine whether endocannabinoid 
signaling was involved in either type of reinstatement, the CB1 
receptor antagonist AM-251 was injected before FS and cocaine. AM-
251 treatment completely blocked the forced swim-induced 
reinstatement (no significant difference in the time spent in the 
cocaine-paired environment between the extinction and reinstatement 
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day within the AM+FS group and a significant effect of treatment 
within reinstatement days between FS and AM+FS, p<0.05, Holm 
Sidak). AM-251 treatment did not block cocaine-induced reinstatement 
(significant effect of time in both Coc and Coc+AM, p<0.05, Holm-
Sidak, no significant difference between reinstatement days with Coc 
vs Coc+AM-251). Neither AM-251 nor vehicle produced any 
reinstatement when given alone. 
 
Figure 1 The effect of the cannabinoid antagonist AM-251 on forced swim- and 
cocaine-induced reinstatement. Data represent the time spent in the cocaine-paired 
compartment (mean +/- SEM) during the extinction session prior to reinstatement 
testing and after reinstatement testing with forced swim (6 minutes) + vehicle (FS), 
FS + AM-251(3 mg/kg, i.p.) (FS+AM), cocaine (15 mg/kg, i.p) + vehicle (Coc), 
cocaine + AM-251 (Coc+AM), vehicle, or AM-251. Vehicle and AM-251 were injected 
30 minutes prior to reinstatement testing. Coc and FS were administered immediately 
prior to reinstatement testing. A significant increase in the time spent in the cocaine-
paired compartment during reinstatement testing compared to the preceding 
extinction session was seen after both FS and cocaine (* =p<0.05, Holm-Sidak 
multiple comparison test) but not after AM-251 or vehicle alone. A significant 
difference between the time spent in the cocaine-paired compartment on 
reinstatement days was seen between the FS and FS+AM251 treatment groups (@ = 
p<0.05, Holm-Sidak multiple comparison test) but not between the Coc and the Coc + 
AM-251 groups. 
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The effect of CP 55,940 on reinstatement of place 
preference for cocaine 
Mice which had been conditioned to cocaine and whose place 
preference had been extinguished were tested with vehicle and three 
doses of the CP 55,940 to determine if administration of a cannabinoid 
agonist was sufficient to induce reinstatement of place preference 
(Figure 2). No reinstatement was observed following 10, 20 or 40 
μg/kg administration of CP 55,940 (F(1,21)=0.0875, p=0.776, main 
effect of time (extinction vs. reinstatement day), two-way RM ANOVA). 
 
Figure 2 The effect of the cannabinoid agonist CP 55,940 on reinstatement of 
extinguished cocaine-induced conditioned place preference. Data represent the time 
spent in the cocaine-paired compartment (mean +/- SEM) during the extinction 
session prior to reinstatement testing and after reinstatement testing with vehicle 
(Veh) or 10, 20 or 40 μg/kg, i.p. CP-55,940, 30 min prior to testing. There were no 
significant differences (two way RM ANOVA). 
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The involvement of noradrenergic mechanisms in 
cannabinoid mediation of cocaine place preference 
In order to examine the interaction between cannabinergic and 
noradrenergic systems in cocaine reinstatement, another group of 
mice which had been conditioned to cocaine and whose place 
preference had been extinguished were tested with either 1) vehicle, 
2) the alpha-2 adrenergic antagonist BRL-44408 (5 mg/kg, i.p.) or 3) 
BRL-44408 (5 mg/kg, i.p.) and CP 55,940 (20 μg/kg). BRL-44408 
alone did not induce reinstatement but when combined with the non-
reinstating dose of CP 55,940, reinstatement was induced 
(F(2,20)=3.499, p<0.05, main effect of treatment, two-way RM 
ANOVA followed by Holm-Sidak multiple comparisons, P<0.05, Figure 
3). 
 
Figure 3 The effect of combined administration of subthreshold doses of the 
cannabinoid agonist CP-55,940 and the alpha-2 adrenergic antagonist BRL-44408 on 
reinstatement of extinguished cocaine-induced conditioned place preference. Data 
represent the time spent in the cocaine-paired compartment (mean +/- SEM) during 
the extinction session prior to reinstatement testing and after reinstatement testing 
with vehicles (Veh + Veh), BRL-44408 (5 mg/kg, i.p.) and vehicle (BRL+ Veh), and 
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BRL-44408 and CP 55,940 (20 μg/kg, i.p.) (CP+BRL). All injections were administered 
30 min prior to reinstatement testing. A significant increase in the time spent in the 
cocaine-paired compartment during reinstatement testing compared to the preceding 
extinction session was seen after administration of CP and BRL (* =p<0.05, Holm-
Sidak multiple comparison test) but not after BRL or vehicle alone. A significant 
difference between the time spent in the cocaine-paired compartment on 
reinstatement days was seen between the CP+BRL and the BRL+Veh and the 
Veh+Veh treatment groups (@ = p<0.05, Holm-Sidak multiple comparison test). 
Discussion 
We found that systemic administration of a cannabinoid 
antagonist can reverse stress- but not cocaine-induced reinstatement 
of cocaine seeking behavior in male C57Bl/6 mice. Cannabinoid 
receptors are located in many brain areas involved in stress and 
addiction (Herkenham et al., 1990; Mailleux and Vanderhaeghen, 
1992). They influence the release of multiple neurotransmitters, 
including GAB A, glutamate, norepinephrine and dopamine (Lopez-
Moreno et al., 2008). Given the widespread distribution of cannabinoid 
receptors and the multiplicity of neurotransmitter systems with which 
the ECS interacts, it is not surprising that the effects of systemic 
administration of cannabinoid agonists and antagonists have complex 
and even contradictory effects on addictive behavior. In particular, 
several studies which used rats to examine the effect of cannabinoids 
on cocaine reinstatement using a cocaine self-administration model 
found that cannabinoid antagonists block cocaine-induced 
reinstatement (De Vries et al., 2001; Filip et al., 2006 ; Xi et al., 
2006) but not stress-induced reinstatement of cocaine seeking 
behavior (De Vries et al., 2001). In contrast, Ward et al., (2009) found 
that a cannabinoid antagonist did not block cocaine-induced 
reinstatement in mice. It is possible that different aspects of 
endocannabinoid effects on addiction are being revealed in studies that 
use different species, different tests to measure relapse, different 
drugs and dosages, and different stress paradigms. 
The neurochemical pathways that mediate cocaine- and stress-
induced reinstatement are not identical. There is evidence that stress-
induced but not cocaine-induced reinstatement involves brain 
noradrenergic pathways, in particular noradrenergic systems that 
terminate in the bed nucleus of the stria terminalis (BNST) and central 
nucleus of the amygdala (Leri et al., 2002). In rat self administration 
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models of cocaine reinstatement, treatments that reduce 
noradrenergic signaling, either by blocking beta adrenergic receptors 
(Leri et al., 2002) or suppressing the release of NE by alpha-2 
adrenergic receptor activation (Erb et al 2000), reduce stress-induced 
but not cocaine-induced reinstatement of cocaine seeking. In addition, 
Mantsch et al., (2010) reported that beta adrenergic receptor 
antagonists or drugs that decrease NE release block stress-induced 
reinstatement but not cocaine-induced reinstatement using the mouse 
conditioned place preference methodology. 
It is possible that the ECS plays a role in stress-induced 
reinstatement by enhancing the release of NE. We found that systemic 
injection of the cannabinoid agonist, CP 55,940 could not induce 
reinstatement when injected alone, but did cause reinstatement when 
combined with a non-reinstating dose of BRL-44408, an alpha-2A 
adrenergic antagonist that causes increased release of NE. Stress has 
been shown to alter endocannabinoid concentrations (Patel and Hillard, 
2008; Cota, 2008; Hill et al., 2010) and there is significant interaction 
between the endocannabinoid and noradrenergic systems. Cannabinoid 
receptors are present in the locus coeruleus (LC) and nucleus of the 
solitary tract, noradrenergic brainstem nuclei that project to forebrain 
areas including the BNST (Herkenham et al., 1991) and 
electrophysiological studies have demonstrated that cannabinoid 
agonists affect firing rates of neurons in the LC (Mendiguren and 
Pineda, 2006; Muntoni et al., 2006). Further, the cannabinoid agonist 
WIN 55,212-2 increases c-fos expression in the LC (Patel and Hillard, 
2003) and increases forebrain NE release as well as increase indices of 
noradrenergic activity (Oropeza et al., 2005; Page et al., 2007; Page 
et al., 2008). In addition to possibly acting on brain stem 
noradrenergic projection neurons, endocannabinoids could also be 
acting within the BNST. CB1 receptors have been localized on 
presynaptic excitatory and inhibitory synaptic terminals within the 
BNST (Puente et al., 2010) and mRNA for CB1 receptors has been 
found in both projection neurons to the BNST as well as in intrinsic 
inhibitory neurons (Matsuda et al., 1993). The CB1 receptors within 
the BNST have been linked anatomically and functionally to reward 
pathways (Massi et al., 2008; Grueter et al., 2006). 
Alternative hypotheses regarding the interaction of 
cannabinergic and noradrenergic systems are also possible. For 
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example, activation of CB1 receptors on GABAergic terminals could 
suppress inhibition of neurons downstream from NE release in the 
BNST. 
The hypothesis that the ECS may serve as a link between stress 
and noradrenergic dependent processes has also been proposed for 
the consolidation of aversive memories. It is known that noradrenergic 
transmission within the basolateral amygdala is critical for stress-
induced enhancement of memory consolidation (Roozendaal et al., 
2002; Roozendaal et al., 2004; Roozendaal et al., 2006). Campolongo 
et al., (2009) have found that cannabinoid antagonists impair and 
cannabinoid agonists enhance stress-induced memory consolidation 
and have proposed that stress may act to enhance memory, at least in 
part, by stimulating the release of endocannabinoids which then lead 
to the release of NE. 
Although the results of this study support a possible interaction 
between the ECS and noradrenergic systems in stress-induced 
reinstatement of cocaine seeking behavior, blockade of swim stress-
induced reinstatement by AM-251 may also reflect the interaction of 
the ECS with other brain pathways and neurotransmitters. For 
example, the ECS has been implicated in the regulation of stress 
response by the hypothalamic-pituitary-adrenal axis, as well as the 
release of numerous neurotransmitter systems involved in addiction, 
including GABA, glutamate, dopamine, serotonin, acetylcholine and 
neuropeptides (Lopez-Moreno). The interaction of the ECS with these 
systems in stress-induced reinstatement remains to be investigated. 
We found that a cannabinoid antagonist blocks stress- but not 
cocaine-induced reinstatement of cocaine seeking behavior in mice. 
Further, we have found that non-reinstating dose of a cannabinoid 
agonist and a non-reinstating dose of an alpha-2 adrenergic 
autoreceptor antagonist synergize to produce reinstatement. These 
results are consistent with the hypothesis that stress exposure but not 
cocaine triggers the endogenous activation of CB1 receptors and that 
the ECS interacts with noradrenergic mechanisms to influence stress-
induced reinstatement of cocaine-seeking behavior. 
  
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience, Vol. 204 (March 2012): pg. 117-124. DOI. This article is © Elsevier and permission has been granted for this 
version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
16 
 
Highlights 
 Endocannabinoids and stress-induced cocaine reinstatement 
 Cannabinoid antagonist AM-251 blocks stress- induced cocaine 
reinstatement 
 Cannabinoid antagonist AM-251 does not block cocaine-induced 
cocaine reinstatement 
 Cannabinoid agonist does not induce cocaine reinstatement 
 Cannabinoid and noradrenergic agents synergize to induce cocaine 
reinstatement 
Acknowledgments: This work was supported by National Institute on Drug 
Abuse (NIDA) grant number DA15758 to JRM, and DA09155 to CJH, and a 
Marquette University COR RRG to LKV. 
Abbreviations 
NE norepinephrine 
LC locus coeruleus 
BNST bed nucleus of the stria terminalis 
RM repeated measures 
FS forced swim 
ECS endocannabinoid system 
Footnotes 
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has 
been accepted for publication. As a service to our customers we are providing 
this early version of the manuscript. The manuscript will undergo copyediting, 
typesetting, and review of the resulting proof before it is published in its final 
citable form. Please note that during the production process errors may be 
discovered which could affect the content, and all legal disclaimers that apply 
to the journal pertain. 
References 
Abercrombie ED, Keller RW, Jr, Zigmond MJ. Characterization of hippocampal 
norepinephrine release as measured by microdialysis perfusion: 
pharmacological and behavioral studies. Neuroscience. 1988;27:897–
904. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience, Vol. 204 (March 2012): pg. 117-124. DOI. This article is © Elsevier and permission has been granted for this 
version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
17 
 
Barna I, Zelena D, Arszovszki AC, Ledent C. The role of endogenous 
cannabinoids in the hypothalamo-pituitary-adrenal axis regulation: in 
vivo and in vitro studies in CB1 receptor knockout mice. Life Sci. 
2004;75:2959–2970. 
Baumann MH, Milchanowski AB, Rothman RB. Evidence for alterations in 
alpha2-adrenergic receptor sensitivity in rats exposed to repeated 
cocaine administration. Neuroscience. 2004;125:683–90. 
Belej T, Manji D, Sioutis S, Barros HM, Nobrega JN. Changes in serotonin and 
norepinephrine uptake sites after chronic cocaine: pre- vs. post-
withdrawal effects. Brain Res. 1996;736:287–96. 
Beveridge TJ, Smith HR, Nader MA, Porrino LJ. Effects of chronic cocaine self 
administration on norepinephrine transporters in the nonhuman 
primate brain. Psychopharmacology. 2005;180:781–788. 
Campolongo P, Roozendaal B, Trezza V, Hauer D, Schelling G, McGaugh JL, 
Cuomo V. Endocannabinoids in the rat basolateral amygdale enhance 
memory consolidation and enable glucocorticoid modulation of 
memory. Proc Natl Acad Sci USA. 2009;106:4888–4893. 
Childress AR, Ehrman R, Rohsenow DJ, Robbins SJ, O'Brien CP. Classically 
conditioned factors in drug dependence. In: Lowinson JH, Ruiz P, 
Millman RB, editors. Substance abuse: a comprehensive textbook. 
Baltimore: Williams and Wilkins; 1992. pp. 56–69. 
Cohen C, Kodas E, Griebel G. CB1 receptor antagonists for the treatment of 
nicotine addiction. Pharmacol Biochem Behav. 2005;81:387–395. 
Cota D. The role of the endocannabinoid system in the regulation of 
hypothalamic-pituitary-adrenal axis activity. J Neuroendocrinol. 
2008;20(1):35–38. 
Cota D, Steiner MA, Marsicano G, Cervino C, Herman JP, Grubler Y, Stalla J, 
Pasquali R, Lutz B, Stalla GK, Pagotto U. Requirement of cannabinoid 
receptor type 1 for the basal modulation of hypothalamic-pituitary 
adrenal axis function. Endocrinology. 2007;148:1574–1581. 
De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, 
Vanderschuren LJ, Schoffelmeer AN. A cannabinoid mechanism in 
relapse to cocaine seeking. Nat Med. 2001;7:1151–1154. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience, Vol. 204 (March 2012): pg. 117-124. DOI. This article is © Elsevier and permission has been granted for this 
version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
18 
 
Di S, Malcher-Lopes R, Marcheselli VL, Bazan NG, Tasker JG. Rapid 
glucocorticoid-mediated endocannabinoid release and opposing 
regulation of glutamate and GABA inputs to hypothalamic 
magnocellular neurons. Endocrinology. 2005;146:4292–4301. 
Erb S, Hitchcott PK, Rajabi H, Mueller D, Shaham Y, Stewart J. Alpha-2 
adrenergic receptor agonists block stress-induced reinstatement of 
cocaine seeking. Neuropsychopharmacology. 2000;23:138–150. 
Fattore L, Martellotta MC, Cossu G, Mascia MS, Fratta W. CB1 cannabinoid 
receptor agonist WIN 55,212-2 decreases intravenous cocaine self 
administration in rats. Behav Brain Res. 1999;104:141–146. 
Filip M, Golda A, Zaniewska M, McCreary AC, Nowak E, Kolasiewicz W, 
Przegalinski E. Involvement of cannabinoid CB1 receptors in drug 
addiction: effects of rimonabant on behavioral responses induced by 
cocaine. Pharmacol Rep. 2006;58:806–819. 
Finlay JM, Zigmond MJ, Abercrombie ED. Increased dopamine and 
norepinephrine release in the medial prefrontal cortex induced by 
acute and chronic stress: effects of diazepam. Neuroscience. 
1995;64:619–628. 
Gardner EL. Endocannabinoid signaling system and brain reward: emphasis 
on dopamine. Pharmacol Biochem Behav. 2005;81:263–84. 
Gorzalka BB, Hillard CJ, Hill MM. Regulation of endocannabinoid signaling by 
stress: implications for stress-related affective disorders. Neurosci 
Biobehav Rev. 2008;32:1152–60. 
Grueter BA, Gosnell HB, Olsen CM, Schramm-Sapyta NL, Nekrasova T, et al. 
Extracellular-signal regulated kinase 1-dependent metabotropic 
glutamate receptor 5-induced long-term depression in the bed nucleus 
of the stria terminalis is disrupted by cocaine administration. J 
Neurosci. 2006;26:3210–3219. 
Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC. 
Characterization and localization of cannabinoid receptors in rat brain: 
a quantitative in vitro autoradiographic study. J Neurosci. 
1991;11:563–583. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience, Vol. 204 (March 2012): pg. 117-124. DOI. This article is © Elsevier and permission has been granted for this 
version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
19 
 
Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice 
KC. Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA. 
1990;87:1932–1936.  
Hill MN, McLaughlin RJ, Bingham B, Shrestha L, Lee TT, Gray JM, Hillard CJ, 
Gorzalka BB, Viau V. Endogenous cannabinoid signaling is essential for 
stress adaptation. Proc Natl Acad Sci U S A. 2010;107:9406–9411. 
Hill MN, McLaughlin RJ, Morrish AC, Viau V, Floresco SB, Hillard CJ, Gorzalka 
BB. Suppression of amygdalar endocannabinoid signaling by stress 
contributes to activation of the hypothalamic-pituitary-adrenal axis. 
Neuropsychopharmacology. 2009;34:2733–45. 
Itzhak Y, Martin JL. Cocaine-induced conditioned place preference in mice: 
induction, extinction and reinstatement by related psychostimulants. 
Neuropsychopharmacology. 2002;26:130–134. 
Kalivas PW, McFarland K. Brain circuitry and the reinstatement of cocaine-
seeking behavior. Psychopharmacology (Berl) 2003;168:44–56. 
Kreibich AS, Blendy JA. cAMP response element-binding protein is required for 
stress but not cocaine-induced reinstatement. J Neurosci. 
2004;224:6686–6692. 
Lanteri C, Salomon L, Torrens Y, Glowinski J, Tassin JP. Drugs of abuse 
specifically sensitize noradrenergic and serotonergic neurons via a 
non-dopaminergic mechanism. Neuropsychopharmacology. 
2008;33:1724–34. 
Leri F, Flores J, Rodaros D, Stewart J. Blockade of stress-induced but not 
cocaine-induced reinstatement by infusion of noradrenergic 
antagonists into the bed nucleus of the stria terminalis or the central 
nucleus of the amygdala. J Neurosci. 2002;22:5713–5718. 
López-Moreno JA, González-Cuevas G, Moreno G, Navarro M. The 
pharmacology of the endocannabinoid system: functional and 
structural interactions with other neurotransmitter systems and their 
repercussions in behavioral addiction. Addict Biol. 2008;13:160–87. 
Lupica CR, Riegel AC, Hoffman AF. Marijuana and cannabinoid regulation of 
brain reward circuits. Br J Pharmacol. 2004;143:227–234. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience, Vol. 204 (March 2012): pg. 117-124. DOI. This article is © Elsevier and permission has been granted for this 
version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
20 
 
Macey DJ, Smith HR, Nader MA, Porrino LJ. Chronic cocaine self-
administration upregulates the norepinephrine transporter and alters 
functional activity in the bed nucleus of the stria terminalis of the 
rhesus monkey. J Neurosci. 2003;23:12–16. 
Mailleux P, Vanderhaeghen JJ. Distribution of neuronal cannabinoid receptor 
in the adult rat brain: a comparative receptor binding radioautography 
and in situ hybridization histochemistry. Neuroscience. 1992;48:655–
668. 
Mantsch JR, Weyer A, Vranjkovic O, Beyer CE, Baker DA, Caretta H. 
Neuropsychopharmacol. 2010;35:2165–2178.  
Manzanares J, Corchero J, Fuentes JA. Opioid and cannabinoid receptor 
mediated regulation of the increase in adrenocorticotropin hormone 
and corticosterone plasma concentrations induced by central 
administration of delta (9)-tetrahydrocannabinol in rats. Brain Res. 
1999;839:173–179. 
Massi L, Elezgarai I, Puente N, Reguero L, Grandes P, Manzoni OJ, Georges F. 
Cannabinoid receptors in the bed nucleus of the stria terminalis control 
cortical excitatioin of midbrain dopamine cells in vivo. J Neurosci. 
2008;28:10496–10508. 
Matsuda LA, Bonner TI, Lolait SJ. Localization of cannabinoid receptor mRNA 
in rat brain. J Comp Neurol. 1993;327:535–550. 
Mendiguren A, Pineda J. Systemic effect of cannabinoids on the spontaneous 
firing rate of locus coeruleus neurons in rats. Eur J Pharmacol. 
2006;534:83–88. 
Muntoni AL, Pillolla G, Melis M, Perra S, Gessa GL, Pistis M. Cannabinoids 
modulate spontaneous neuronal activity and evoked inhibition of locus 
coeruleus noradrenergic neurons. Eur J Neurosci. 2006;23:2385–94. 
Orio L, Edwards S, George O, Parsons LH, Koob GF. A role for the 
endocannabinoid system in the increased motivation for cocaine in 
extended-access conditions. 2009.  
Oropeza VC, Page ME, Van Bockstaele EJ. Systemic administration of WIN 
55,212-2 increases norepinephrine release in the rat frontal cortex. 
Brain Res. 2005;1046:45–54. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience, Vol. 204 (March 2012): pg. 117-124. DOI. This article is © Elsevier and permission has been granted for this 
version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
21 
 
Orsini C, Bonito-Oliva A, Conversi D, Cabib S. Genetic liability increases 
propensity to prime-induced reinstatement of conditioned place 
preference in mice exposed to low cocaine. Psychopharmacology. 
2008;198:287–296. 
Page ME, Oropeza VC, Sparks SE, Qian Y, Menko AS, Van Bockstaele EJ. 
Repeated cannabinoid administration increases indices of 
noradrenergic activity in rats. Pharmacol Biochem Behav. 
2007;86:162–168. 
Page ME, Oropeza VC, Van Bockstaele EJ. Local administration of a 
cannabinoid agonist alters norepinephrine efflux in the rat frontal 
cortex. Neurosci Lett. 2008;431:1–5.  
Patel S, Hillard CJ. Cannabinoid-induced Fos expression within A10 
dopaminergic neurons. Brain Res. 2003;963:15–25. 
Patel S, Hillard CJ. Adaptations in endocannabinoid signaling in response to 
repeated homotypic stress: A novel mechanism for stress habituation. 
Eur J Neurosci. 2008;27:2821–2829.  
Patel S, Roelke CT, Rademacher DJ, Cullinan WE, Hillard CJ. Endocannabinoid 
signaling negatively modulates stress-induced activation of the 
hypothalamic-pituitary-adrenal axis. Endocrinology. 2004;145:5431–
5438. 
Puente N, Elezgarai I, Lafourcade M, Reguero L, Marsicano G, Georges F, 
Manzoni OJ, Grandes P. Localization and function of the cannabinoid 
CB1 receptor in the anterolateral bed nucleus of the stria terminalis. 
PLoS One. 2010;5:e8869.  
Rademacher DJ, Meier SE, Shi L, Ho WS, Jarrahian A, Hillard CJ. Effects of 
acute and repeated restraint stress on endocannabinoid content in the 
amygdala, ventral striatum, and medial prefrontal cortex in mice. 
Neuropharmacology. 2008;54:108–16. 
Redila VA, Chavkin C. Stress-induced reinstatement of cocaine seeking is 
mediated by the kappa opioid system. Psychopharmacology. 
2008;200:59–70. 
Ribeiro Do Couto B, Aguilar MA, Manzanedo C, Rodríguez-Arias M, Armario A, 
Miñarro J. Social stress is as effective as physical stress in reinstating 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience, Vol. 204 (March 2012): pg. 117-124. DOI. This article is © Elsevier and permission has been granted for this 
version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
22 
 
morphine-induced place preference in mice. Psychopharmacology. 
2006;185:459–470. 
Roozendaal B, de Quervain DJ, Schelling G, McGaugh JL. A systemically 
administered beta-adrenoceptor antagonist blocks corticosterone-
induced impairment of contextual memory retrieval in rats. Neurobiol 
Learn Mem. 2004;81:150–154. 
Roozendaal B, Okuda S, Van der Zee EA, McGaugh JL. Glucocorticoid 
enhancement of memory requires arousal-induced noradrenergic 
activation in the basolateral amygdala. Proc Natl Acad Sci USA. 
2006;103:6741–6746.  
Roozendaal B, Quirarte GL, McGaugh JL. Glucocorticoids interact with the 
basolateral amygdala beta-adrenoceptor–cAMP/PKA system in 
influencing memory consolidation. Eur J Neurosci. 2002;15:553–560. 
See RE, Grimm JW, Kruzich PJ, Rustay N. The importance of a compound 
stimulus in conditioned drug-seeking behavior following one week of 
extinction from self-administered cocaine in rats. Drug Alcohol 
Depend. 1999;57:41–49. 
Shaham Y, Erb S, Stewart J. Stress-induced relapse to heroin and cocaine 
seeking in rats: a review. Brain Res Brain Res Rev. 2000;33:13–33. 
Shaham Y, Shalev U, Lu L, De Wit H, Stewart J. The reinstatement model of 
drug relapse: history, methodology, and major findings. 
Psychopharmacology. 2003;168:3–20. 
Sofuoglu M, Sewell RA. Norepinephrine and stimulant addiction. Addict Biol. 
2009;14:119–129. 
Soria G, Mendiza′bal V, Tourin∼o C, Robledo P, Ledent C, Parmentier M, 
Maldonado R, Valverde O. Lack of CB1 cannabinoid receptor impairs 
cocaine self-administration. Neuropsychopharmacology. 
2005;30:1670–1680. 
Stewart J. Pathways to relapse: the neurobiology of drug- andstress-induced 
relapse to drug-taking. J Psychiatry Neurosci. 2000;25:125–136. 
Tanaka T, Yokoo H, Mizoguchi K, Yoshida M, Tsuda A, Tanaka M. 
Noradrenaline release in the rat amygdala is increased by stress: 
studies with intracerebral microdialysis. Brain Res. 1991;544:174–176. 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Neuroscience, Vol. 204 (March 2012): pg. 117-124. DOI. This article is © Elsevier and permission has been granted for this 
version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
23 
 
Tanda G, Goldberg SR. Cannabinoids reward, dependence, and underlying 
neurochemical mechanisms-a review of recent preclinical data. 
Psychopharmacology (Berl) 2003;169:115–134. 
Tzschentke TM. Measuring reward with the conditioned place preference (CPP) 
paradigm: update of the last decade. Addict Biol. 2007;12:227–462. 
Wade MR, Degroot A, Nomikos GG. Cannabinoid CB1 receptor antagonism 
modulates plasma corticosterone in rodents. Eur J Pharmacol. 
2006;551:162–167. 
Ward SJ, Rosenberg M, Dykstra LA, Walker EA. The CB1 antagonist 
rimonabant (SR141716) blocks cue induced reinstatement of cocaine 
seeking and other context and extinction phenomena predictive of 
relapse. Drug Alcohol Depend. 2009;105:248–255. 
Wiskerke J, Pattij T, Schoffelmeer AN, De Vries TJ. The role of CB1 receptors 
in psychostimulant addiction. Addict Biol. 2008;13:225–238. 
Xi ZX, Gilbert JG, Peng XQ, Pak AC, Li X, Gardner EL. Cannabinoid CB1 
receptor antagonist AM251 inhibits cocaine-primed relapse in rats: role 
of glutamate in the nucleus accumbens. J Neurosci. 2006;26:8531–
8536. 
Xi ZX, Spiller K, Pak AC, Gilbert J, Dillon C, Li X, Peng XQ, Gardner EL. 
Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding 
effects: experiments with self-administration and brain-stimulation 
reward in rats. Neuropsychopharmacology. 2008;33:1735–1745. 
About the Authors 
John R. Mantsch: John.Mantsch@marquette.edu; Cecilia J. Hillard: 
Chillard@mcw.edu  
Corresponding Author: Linda K. Vaughn, Ph.D., Department of Biomedical 
Sciences, PO Box 1881, Milwaukee, WI 53201, Tel:1- 414-288-6566, 
Fax: 1-414-288-6566, Email: Linda.Vaughn@marquette.edu  
 
